Back

Hyperkalaemia in patients with heart failure – Addressing the unmet medical need.

25 May 2019 (12:20 - 12:35)
Organised by:
Congress Presentation Part of: Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy Comorbidities HFA Premium Access Heart Failure 2019

About the speaker

Photo
Professor Mitja Lainscak

General Hospital Murska Sobota, Murska Sobota (Slovenia)

4 More presentations in this session

Presentation thumbnail
Welcome and introduction - Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.
Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Slides Video
Presentation thumbnail
New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension and chronic kidney disease – The cardiologist’s perspective.
Professor I. Pina (Philadelphia, US)
Slides Video
Presentation thumbnail
New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension and chronic kidney disease – The nephrologist’s perspective.
Professor P. Rossignol (Monaco, MC)
Slides Video
Presentation thumbnail
Panel discussion and close - Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.
Professor J. Butler (Dallas, US)
Slides

Access the full session

Session thumbnail
Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy

The Event

Event poster

Heart Failure 2019

25 May 2019 12:20 CET
You may be interested in
thumbnail
Congress Presentation
Comorbidity burden assessed by the Charlson comorbidity index and its influence on prognosis of patients admitted due to heart failure
thumbnail
Congress Presentation
Spectrum of non-cardiac comorbidities
thumbnail
Congress Presentation
Clinical characteristics of newly diagnosed vs. chronic heart failure patients in Spain: SEC-Excelente registry results.

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources